Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
58 /100
HIGH RISK
Score updated Oct 13, 2026

NGNE — Neurogene Inc. Dilution Risk Tracker

Track NGNE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NGNE — Get alerts when the score changes →

As of October 13, 2026, Neurogene Inc. (NGNE) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. Neurogene Inc. has a market capitalization of $489.08M, 20.01M shares outstanding, 98 institutional holders tracked. Stored dilution-related fields include 12.66M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
10
📊 Float Risk
95
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 63% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track NGNE — Get forecast alerts →

Market Data

Market Cap$489.08M
Shares Outstanding20.01M
Float6.01M
Cash$225.39M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore58/100DilutionWatch score record
Shares Outstanding20.01MVerified float table or market cache
Public Float6.01MVerified float table or market cache
Market Cap$489.08MMarket data cache
Cash Runway33.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants12.66MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 13.3% shares (2026Q1 vs prior)
98 institutional holders · 18.82M shares
#1 SAMSARA BIOCAPITAL, LLC 1.72M shares
#2 Redmile Group, LLC 1.46M shares
#3 Casdin Capital, LLC 1.42M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.97M
Days to Cover11.7
% of Float82.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-03-24
xbrl XBRL WARRANT 2024-11-18
4 INSIDER TRANSACTION 2026-03-30
4 INSIDER TRANSACTION 2026-03-30
4 INSIDER TRANSACTION 2026-03-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NGNE Dilution Snapshot

Neurogene Inc. (NGNE) has a DilutionScore of 58/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NGNE's DilutionScore is currently 58/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 46/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202658/100HIGH14 days
Aug 14 – Sep 29, 202646/100MEDIUM46 days
Jul 16 – Aug 13, 202648/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NGNE shares outstanding have increased 2.0% from 15.49M (Mar 2026) to 15.80M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 202615.80M6.01M▲ 0.16%
May 21, 202615.80M6.00M▲ 0.15%
May 18, 202615.80M5.99M▼ 2.04%
May 16, 202615.80M6.11M▲ 17.48%
May 14, 202615.80M5.20M▲ 1.46%
Apr 26, 202615.62M5.13M▲ 0.54%
Apr 11, 202615.57M5.10M▼ 0.17%
Apr 03, 202615.57M5.11M▲ 0.38%
Mar 27, 202615.57M5.09M▲ 1.14%
Mar 26, 202615.49M5.03M▲ 0.55%
Mar 15, 202615.49M5.01M▲ 0.10%
Mar 05, 202615.49M5.00M▼ 0.94%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NGNE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NGNE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NGNE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations